L’Oreal’s anti-wrinkle cosmetics infringe, claims GlycoBioSciences

Canadian pharmaceutical company GlycoBioSciences has sued cosmetics giant L’Oreal, alleging that the French company’s anti-wrinkle products containing hyaluronic acid infringe two patents.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

article

L’Oreal prevails in anti-aging treatment clash

12 January 2023 Dispute concerns two of the cosmetic giant’s best-selling brands | Arguments revolved around whether the French company could be sued in the US.

Americas

L’Oreal wins infringement suit over ‘indefinite’ patents

22 April 2021 L’Oreal has secured a victory after a US federal court ruled that the French cosmetics brand did not infringe patents owned by the University of Massachusetts because they were invalid.

Americas

Allergan sues cosmetics companies for trademark infringement

7 April 2017 Allergan has filed a complaint against cosmetics companies Dermavita and Dima and PR company KBC Media for trademark infringement and false advertising.

More features

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

Barnes & Thornburg reveals five new IP leaders

L’Oreal’s anti-wrinkle cosmetics infringe, claims GlycoBioSciences

More on this story

Editor's picks

Editor's picks

More features